Association between cirrhosis and Helicobacter pylori infection: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 12, 2014, Pages 1309-1319

  Feng, Hao ^a,b   Zhoua, Xiaoying ^a   Zhang, Guoxin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Gastroenterology   (China)

Author keywords

Cirrhosis; Helicobacter pylori; Meta analysis

Indexed keywords

ALCOHOL LIVER CIRRHOSIS; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; INFECTION RATE; LIVER CIRRHOSIS; META ANALYSIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; RISK; RISK FACTOR;

ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 84927694491     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000220     Document Type: Review

References (49)

1. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020-1022.
2. Sherlock S, Dooley J. Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications; 1997.
3. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996; 11:59-64.
4. Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22:633-641.
5. TsaiCJ. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 1998; 43:1219-1225.
6. Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14:717-722.
7. Lo GH, Yu HC, Chan YC, Chen WC, Hsu PI, Lin CK, Lai KH. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 2005; 62:350-356.
8. Rosina F, Alaria P, Castelli S, Dirindin N, Rocca G, Actis GC, et al. Effect of patient characteristics on hospital costs for cirrhosis: implications for the disease-related group (DRG) reimbursement system. Ital J Gastroenterol 1996; 28:401-405.
9. Dousset B, Suc B, Boudet MJ, Cherqui D, Rotman N, Julien M, Fagniez PL. Surgical treatment of severe ulcerous hemorrhages: predictive factors of operative mortality. Gastroenterol Clin Biol 1995; 19:259-265.
10. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10:720-741.
11. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19:449-490.
12. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168:219-221.
13. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 2012; 30:677-706.
14. Takuma Y. Helicobacter pylori infection and liver diseases. Gan To Kagaku Ryoho 2011; 38:362-364.
15. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008; 8:254-260.
16. Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol 2003; 29:351-359.
17. Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37:1026-1033.
18. LeVeen HH, LeVeen EG, LeVeen RF. Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy. Biomed Pharmacother 1994; 48:157-166.
19. Schulz C, Schütte K, Malfertheiner P. Does H. Pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol 2014; 48:491-499.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
22. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006; 25:3443-3457.
23. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29:559-578.
24. Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, et al. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med 2013; 51:1075-1082.
25. Shapira Y, Agmon-Levin N, Renaudineau Y, Porat-Katz BS, Barzilai O, Ram M, et al. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Exp Mol Pathol 2012; 93:386-390.
26. Silva LD, Rocha AM, Rocha GA, de Moura SB, Rocha MM, Dani R, et al. The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient. Mem Inst Oswaldo Cruz 2011; 106:748-754.
27. Chen R, Chen XP, Lin QQ, Lin BL, Cao HJ. Detection of Helicobacter species related genes coding for 16S rRNA in the liver tissue of patients with chronic liver disease. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30:131-132.
28. El-Masry S, El-Shahat M, Badra G, Aboel-Nour MF, Lotfy M. Helicobacter pylori and hepatitis C virus coinfection in Egyptian patients. J Glob Infect Dis 2010; 2:4-9.
29. Ibrişim D, Cevikbaş U, Akyüz F, Poturoʇlu S, Ahishali E, Güllüoʇlu M, et al. Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology. Eur J Gastroenterol Hepatol 2008; 20:874-880.
30. Kim DJ, Kim HY, Kim SJ, Hahn TH, Jang MK, Baik GH, et al. Helicobacter pylori infection and peptic ulcer disease in patients with liver cirrhosis. Korean J Intern Med 2008; 23:16-21.
31. Castéra L, Pedeboscq A, Rocha M, Le Bail B, Asencio C, de Lédinghen V, et al. Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study. World J Gastroenterol 2006; 12:7278-7284.
32. Nam YJ, Kim SJ, Shin WC, Lee JH, Choi WC, Kim KY, Han TH. Gastric pH and Helicobacter pylori infection in patients with liver cirrhosis. Korean J Hepatol 2004; 10:216-222.
33. Konturek SJ, Gonciarz M, Gonciarz Z, Bielanski W, Mazur W, Mularczyk A, et al. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. Scand J Gastroenterol 2003; 38:643-647.
34. Chen CT, Wang TF, Chan CC, Lee FY, Chang FY, Lin HC, et al. Role of chronic Helicobacter pylori infection in hyperdynamic circulation of cirrhotic patients. Hepatogastroenterology 2002; 49:208-212.
35. Pellicano R, Leone N, Berrutti M, Cutufia MA, Fiorentino M, Rizzetto M, Ponzetto A. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 2000; 33:648-650.
36. Ponzetto A, Pellicano R, Leone N, Berrutti M, Turrini F, Rizzetto M. Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med 2000; 56:206-210.
37. Shimamoto C, Hirata I, Katsu K. Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 2000; 47:443-445.
38. Zullo A, Rinaldi V, Meddi P, Folino S, Lauria V, Diana F, et al. Helicobacter pylori infection in dyspeptic cirrhotic patients. Hepatogastroenterology 1999; 46:395-400.
39. Wang CH, Ma LR, Lin RC, Kuo JY, Chang KK. Helicobacter pylori infection and risk of peptic ulcer among cirrhotic patients. J Formos Med Assoc 1997; 96:55-58.
40. Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, et al. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997; 42:2024-2030.
41. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995; 42:424-427.
42. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54:275-277.
43. Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcântara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter 2010; 15:273-278.
44. Hafsi N, Voland P, Schwendy S, Rad R, Reindl W, Gerhard M, Prinz C. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 2004; 173:1249-1257.
45. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56:772-781.
46. Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102:1808-1825.
47. Feldman M, Cryer B, Lee E, Peterson WL. Role of seroconversion in confirming cure of Helicobacter pylori infection. JAMA 1998; 280:363-365.
48. Huang PN, Li XX, Huang CY. Improved silver staining of H. Pylori in H. Pylori detection. Mod Prev Med 2010; 39:3905-3906, 3909.
49. Schmilovitz-Weiss H, Sehayek-Shabat V, Eliakim R, Skapa E, Avni Y, Shirin H. Applicability of a short/rapid 13C-urea breath test for Helicobacter pylori: retrospective multicenter chart review study. BMC Gastroenterol 2012; 12:8.